financetom
Business
financetom
/
Business
/
BYD launches Denza premium brand in Europe to support expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BYD launches Denza premium brand in Europe to support expansion
Apr 7, 2025 6:12 AM

MILAN (Reuters) - Chinese electric vehicle giant BYD launched on Monday its premium Denza brand in Europe, aiming to support its expansion in the region and compete with top-end German manufacturers such as BMW and Mercedes.

BYD sold over 4.2 million vehicles globally last year, with more than 90% of them in China. Sales of Denza - once a 50:50 joint venture with Mercedes and now fully owned by BYD - accounted for just over 3% of the group's total sales.

The group's special adviser for Europe, Alfredo Altavilla, said Denza would be the technological forerunner for the group.

"It will anticipate tech features that will later appear on BYD brand cars," he said after the presentation at Milan's Design Week, also attended by Executive Vice-President Stella Li.

BYD in 2024 had a 2.8% share of the European EV market, after introducing hybrid vehicles to help expand its reach.

Denza sales in the region will start at the end of the year with the EV version of its 1,000 horsepower Z9 GT sport wagon, and with a hybrid version in early 2026.

The group did not give further details of its commercial strategy and product plans for Europe. The price of the first model, still undisclosed, will exceed the highest car price in BYD's current European range, of 72,000 euros ($78,790).

The Denza range will also include, from the end of this year, the D9 van, while two off-road vehicles could be added in the future, Altavilla said.

"The aim is to make Denza a full-liner premium brand," he said, adding it targets both traditional premium clients and younger customers, who have a particular interest in technology.

The Denza models will be manufactured and exported from China despite BYD planning to start production at its first European plant, in Hungary, in October.

A second BYD site in Turkey is expected to come on line in March 2026. When fully operational, they will have a total production capacity of 500,000 cars per year.

($1 = 0.9138 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eagle Plains And Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, Saskatchewan
Eagle Plains And Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, Saskatchewan
Jun 3, 2026
09:23 AM EDT, 06/03/2026 (MT Newswires) -- Eagle Plains Resources ( EGPLF ) with partner, Xcite Uranium ( XRIUF ) provided initial geophysical results for its 4502 hectares Beaver River Uranium Project, on Wednesday. Strong correlations exist between areas of known uranium mineralization at the VIC and COMBINED zones with trends of anomalous conductivity, the companies said. The Calculated Vertical...
CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise
CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise
Jun 3, 2026
09:21 AM EDT, 06/03/2026 (MT Newswires) -- CytomX Therapeutics ( CTMX ) said Wednesday it is expanding a licensing agreement with Regeneron Pharmaceuticals ( REGN ) to develop conditionally activated bispecific cancer treatments. CytomX said it will receive a $37 million target nomination payment for two newly chosen development programs. Regeneron holds the right to select up to six more...
Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment
Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment
Jun 3, 2026
09:20 AM EDT, 06/03/2026 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Wednesday it is partnering with Bristol Myers Squibb ( BMY ) to develop a treatment regimen for kidney cancer. Arcus said that under the agreement, it will supply its casdatifan drug, which will be evaluated in a Bristol Myers Squibb ( BMY )-sponsored phase 1/2 clinical trial....
RTX Unit Raytheon Awarded $515 Million Contract for Radar Support for US Navy, Germany
RTX Unit Raytheon Awarded $515 Million Contract for Radar Support for US Navy, Germany
Jun 3, 2026
09:27 AM EDT, 06/03/2026 (MT Newswires) -- RTX (RTX) said Wednesday that its Raytheon unit has been awarded a $515 million contract from the US Navy for the SPY-6 family of radars. The company said the sole source award contract is a follow-on to the Integration and Production Support contract, which it won in June of last year, and includes...
Copyright 2023-2026 - www.financetom.com All Rights Reserved